None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. The patients who have subepithelial tumor indicated to be treated with ESSD 2. ECOG performance status 0-2 3. ANC > 1500/mm3, Platelet > 100,000/mm3 4. Creatinine < 1.5 x normal upper level 5. AST, ALT < 2.5 x normal upper level, total bilirubin < 1.5 x normal upper level 6. the patients who agree with informed consent
Exclusion criteria
Exclusion criteria: 1. The patients who are not indicated to ESSD 2. The patients who have allergic history to drug related with treatment 3. The patients who have angina pectoris, acute myocardial infarction, or liver cirrhosis history within 6 months 4. The patients who have severe acute infection 5. The patients who loose medical record
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the mean age, sex, mean operation duration, the mean length of the long axis of the specimen | — |
Secondary
| Measure | Time frame |
|---|---|
| complication | — |
Countries
Korea, Republic of
Contacts
Presbyterian Medical Center